FHD-609 / Foghorn Therap 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
FHD-609 / Foghorn Therap
2021-001488-25: A clinical trial to look at the safety and potential efficacy of FHD-609 in people with advanced synovial sarcoma Un ensayo clínico para estudiar la seguridad y la posible eficacia de FHD-609 en personas con sarcoma sinovial avanzado

Not yet recruiting
1
70
Europe
-, FHD-609, Lyophilisate for solution for infusion
Foghorn Therapeutics Inc., Foghorn Therapeutics Inc.
Advanced Synovial Sarcoma (SS) Sarcoma Sinovial (SS) Avanzado, Synovial Sarcoma (SS) Sarcoma Sinovial (SS), Diseases [C] - Cancer [C04]
 
 
FHD-609-C-001, NCT04965753: FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors

Terminated
1
55
Europe, US
FHD-609
Foghorn Therapeutics Inc.
Advanced Synovial Sarcoma
12/23
12/23

Download Options